Total Funding
22
Total FundingVenture - Series Unknown raised
Growth Score in past quarter
pts
Heat Score 22 in past quarter
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
173456
Serenity Pharmaceuticals is a developer of products that address urinary conditions.
Acquired by 
Acerus Pharmaceuticals
- Seymour Fein: Chief Medical Officer
- Linda Cheng: Vice President, Project Management
About the Company
Serenity Pharmaceuticals is focused on developing products that address urinary conditions that impact the health and well-being of millions of people. Serenity Pharmaceuticals is working to develop patented pharmaceuticals with unique delivery mechanisms and formulations, to provide safe and effective treatments for voiding disorders.
The company
is founded in 2007 and located in Milford, Pennsylvania
Women Founded

